ICM20
- Generic Name
- ICM20
A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- IC-MedTech Corporation
- Target Recruit Count
- 13
- Registration Number
- NCT05523596
- Locations
- 🇺🇸
Culmore Clinic, Falls Church, Virginia, United States
🇺🇸Parkway Medical, Glen Burnie, Maryland, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath